Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sonoma Pharmaceuticals (SNOA) EBITDA: 2011-2012

Historic EBITDA for Sonoma Pharmaceuticals (SNOA) over the last 2 years, with Mar 2012 value amounting to -$7.5 million.

  • Sonoma Pharmaceuticals' EBITDA rose 26.80% to -$1.9 million in Q4 2012 from the same period last year, while for Dec 2012 it was -$4.7 million, marking a year-over-year increase of 36.99%. This contributed to the annual value of -$7.5 million for FY2012, which is 4.83% up from last year.
  • As of FY2012, Sonoma Pharmaceuticals' EBITDA stood at -$7.5 million, which was up 4.83% from -$7.9 million recorded in FY2011.
  • In the past 5 years, Sonoma Pharmaceuticals' EBITDA ranged from a high of -$7.5 million in FY2012 and a low of -$7.9 million during FY2011.
  • Over the past 2 years, Sonoma Pharmaceuticals' median EBITDA value was -$7.7 million (recorded in 2011), while the average stood at -$7.7 million.
  • Data for Sonoma Pharmaceuticals' EBITDA shows a peak YoY increased of 4.83% (in 2012) over the last 5 years.
  • Sonoma Pharmaceuticals' EBITDA (Yearly) stood at -$7.9 million in 2011, then climbed by 4.83% to -$7.5 million in 2012.